258 related articles for article (PubMed ID: 6422505)
1. Human protein C and thromboembolic disease.
Gardiner JE; Griffin JH
Prog Hematol; 1983; 13():265-78. PubMed ID: 6422505
[No Abstract] [Full Text] [Related]
2. Blood coagulation and fibrinolysis in human pregnancy.
Bonnar J
Bibl Anat; 1973; 12():58-63. PubMed ID: 4790392
[No Abstract] [Full Text] [Related]
3. [The behavior of coagulation and fibrinolysis factors with different streptokinase doses].
Poliwoda H; Krohn HP; Steuber H
Med Lab (Stuttg); 1968 Nov; 21(11):252-61. PubMed ID: 5714595
[No Abstract] [Full Text] [Related]
4. The factor VIII complex: structure and function.
Hoyer LW
Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
[TBL] [Abstract][Full Text] [Related]
5. [Protein C--a selective inhibitor of blood coagulation].
Dmoszyńska-Giannopoulou A; Rupniewska ZM
Pol Arch Med Wewn; 1984 May; 71(5):313-6. PubMed ID: 6435099
[No Abstract] [Full Text] [Related]
6. Contribution of natural anticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients.
Shetty S; Vora S; Kulkarni B; Mota L; Vijapurkar M; Quadros L; Ghosh K
Br J Haematol; 2007 Aug; 138(4):541-4. PubMed ID: 17659055
[TBL] [Abstract][Full Text] [Related]
7. Influence of factor V and factor Va on APC-induced cleavage of human factor VIII.
Váradi K; Rosing J; Tans G; Schwarz HP
Thromb Haemost; 1995 Apr; 73(4):730-1. PubMed ID: 7495090
[No Abstract] [Full Text] [Related]
8. Circulating anticoagulants: physiologic and pathophysiologic.
Bussel JB
Hosp Pract (Off Ed); 1983 Feb; 18(2):169-72, 179-83, 186. PubMed ID: 6185409
[No Abstract] [Full Text] [Related]
9. Coagulation factor V and thrombophilia: background and mechanisms.
Segers K; Dahlbäck B; Nicolaes GA
Thromb Haemost; 2007 Sep; 98(3):530-42. PubMed ID: 17849041
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of hemostatic regulations.
Nossel HL
Prog Clin Biol Res; 1981; 72():163-77. PubMed ID: 6801685
[No Abstract] [Full Text] [Related]
11. Quantitation of coagulant antigens and inhibition of activated protein C in combined factor V VIII deficiency.
Giddings JC; Sugrue A; Bloom AL
Br J Haematol; 1982 Nov; 52(3):495-502. PubMed ID: 6812616
[TBL] [Abstract][Full Text] [Related]
12. Activated protein C inhibitor.
Suzuki K
Semin Thromb Hemost; 1984 Apr; 10(2):154-61. PubMed ID: 6330903
[No Abstract] [Full Text] [Related]
13. [Blood coagulation and fibrinolysis inhibitory factors].
Imaoka S; Sasaki Y; Terasawa T
Rinsho Byori; 1985 Jun; Spec No 63():55-61. PubMed ID: 2413229
[No Abstract] [Full Text] [Related]
14. The effect of chronic administration of lathyrogen (beta-aminopropionitrile) on blood clotting and fibrinolytic system in rabbits.
Bańkowski E; Worowski K
Thromb Diath Haemorrh; 1969 Nov; 22(2):372-6. PubMed ID: 5380956
[No Abstract] [Full Text] [Related]
15. Haemostasis in children: anything new?
Han P
Ann Acad Med Singap; 1985 Oct; 14(4):646-53. PubMed ID: 3936394
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of regulation of blood coagulation by activated protein C.
Suzuki K
Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1914-20. PubMed ID: 2941962
[No Abstract] [Full Text] [Related]
17. [Intravascular coagulation and degradation products of fibrinogen and fibrin. (Review of new findings and diagnostic possibilities].
Hrubisková K
Bratisl Lek Listy; 1974; 62(1):111-9. PubMed ID: 4603642
[No Abstract] [Full Text] [Related]
18. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation.
Rapaport SI
Thromb Haemost; 1991 Jul; 66(1):6-15. PubMed ID: 1926052
[No Abstract] [Full Text] [Related]
19. Coagulation abnormalities in liver disease.
Losowsky MS; Simmons AV; Miloszewski K
Postgrad Med; 1973 Jan; 53(1):147-52. PubMed ID: 4682169
[No Abstract] [Full Text] [Related]
20. The natural anticoagulants.
Salem HH
Clin Haematol; 1986 May; 15(2):371-91. PubMed ID: 3015466
[No Abstract] [Full Text] [Related]
[Next] [New Search]
